FI881165A0 - 5-hetero- eller aryl-substituerade imidazo /2,1-a/ isokinoliner. - Google Patents

5-hetero- eller aryl-substituerade imidazo /2,1-a/ isokinoliner.

Info

Publication number
FI881165A0
FI881165A0 FI881165A FI881165A FI881165A0 FI 881165 A0 FI881165 A0 FI 881165A0 FI 881165 A FI881165 A FI 881165A FI 881165 A FI881165 A FI 881165A FI 881165 A0 FI881165 A0 FI 881165A0
Authority
FI
Finland
Prior art keywords
hydrogen
isokinoliner
eller
imidazo
hetero
Prior art date
Application number
FI881165A
Other languages
English (en)
Other versions
FI88159B (fi
FI881165A (fi
FI88159C (fi
Inventor
William Joseph Houlihan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI881165A publication Critical patent/FI881165A/fi
Publication of FI881165A0 publication Critical patent/FI881165A0/fi
Publication of FI88159B publication Critical patent/FI88159B/fi
Application granted granted Critical
Publication of FI88159C publication Critical patent/FI88159C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
FI881165A 1986-07-14 1988-03-11 Foerfarande foer framstaellning av farmaceutiskt aktiva 5-arylsubstituerade-2,3-dihydroimidazo/2,1-a/isokinolinderivat FI88159C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US88511586A 1986-07-14 1986-07-14
US88511586 1986-07-14
US1351587A 1987-02-11 1987-02-11
US1351587 1987-02-11
EP8700366 1987-07-07
PCT/EP1987/000366 WO1988000587A2 (en) 1986-07-14 1987-07-07 5-HETERO- OR ARYL-SUBSTITUTED-IMIDAZO[2,1-a]ISOQUINOLINES

Publications (4)

Publication Number Publication Date
FI881165A FI881165A (fi) 1988-03-11
FI881165A0 true FI881165A0 (fi) 1988-03-11
FI88159B FI88159B (fi) 1992-12-31
FI88159C FI88159C (fi) 1993-04-13

Family

ID=26684931

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881165A FI88159C (fi) 1986-07-14 1988-03-11 Foerfarande foer framstaellning av farmaceutiskt aktiva 5-arylsubstituerade-2,3-dihydroimidazo/2,1-a/isokinolinderivat

Country Status (22)

Country Link
EP (1) EP0258175B1 (fi)
JP (1) JPH01500270A (fi)
KR (1) KR960003609B1 (fi)
AT (1) ATE74357T1 (fi)
AU (1) AU604739B2 (fi)
CA (1) CA1317942C (fi)
CY (1) CY1828A (fi)
DE (1) DE3777919D1 (fi)
DK (1) DK170213B1 (fi)
ES (1) ES2032861T3 (fi)
FI (1) FI88159C (fi)
GR (1) GR3004258T3 (fi)
HK (1) HK71295A (fi)
HU (1) HU206114B (fi)
IE (1) IE60277B1 (fi)
IL (1) IL83164A (fi)
MY (1) MY101895A (fi)
NZ (1) NZ221054A (fi)
PH (1) PH24430A (fi)
PL (1) PL154159B1 (fi)
SG (1) SG8595G (fi)
WO (1) WO1988000587A2 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910206A (en) * 1986-07-14 1990-03-20 Sandoz Pharmaceuticals Corp. 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists
EP0338993A1 (en) * 1988-04-21 1989-10-25 Sandoz Ag 6-Aryl-substituted-4h-thieno[2,3-e][1,2,4]triazolo [3,4-c][1,4]diazepines
DE68921239T2 (de) * 1988-05-05 1995-09-14 Sandoz Ag 5-Aryl-substituierte-2,3-dihydro-imidazo[1,2-a]furo[3,2-c]- oder Thieno[2,3-c]pyridine.
US5939090A (en) 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
CN1076728C (zh) * 1999-02-05 2001-12-26 浙江大学 2－芳基咪唑并[2,1－a]异喹啉的衍生物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1347493A (en) * 1971-02-11 1974-02-27 Aspro Nicholas Ltd Benzazine derivatives

Also Published As

Publication number Publication date
DK138388D0 (da) 1988-03-14
ES2032861T3 (es) 1993-03-01
CY1828A (en) 1995-12-01
PL266801A1 (en) 1988-09-29
EP0258175B1 (en) 1992-04-01
IL83164A0 (en) 1987-12-31
EP0258175A2 (en) 1988-03-02
IL83164A (en) 1991-05-12
SG8595G (en) 1995-06-16
IE871876L (en) 1988-01-14
FI88159B (fi) 1992-12-31
NZ221054A (en) 1990-10-26
EP0258175A3 (en) 1988-05-04
CA1317942C (en) 1993-05-18
PH24430A (en) 1990-06-25
DK138388A (da) 1988-03-14
JPH0588713B2 (fi) 1993-12-24
FI881165A (fi) 1988-03-11
HUT46005A (en) 1988-09-28
FI88159C (fi) 1993-04-13
ATE74357T1 (de) 1992-04-15
WO1988000587A3 (en) 1988-04-07
DE3777919D1 (de) 1992-05-07
JPH01500270A (ja) 1989-02-02
AU604739B2 (en) 1991-01-03
KR880701718A (ko) 1988-11-04
HU206114B (en) 1992-08-28
AU7694187A (en) 1988-02-10
PL154159B1 (en) 1991-07-31
GR3004258T3 (fi) 1993-03-31
IE60277B1 (en) 1994-06-29
KR960003609B1 (en) 1996-03-20
MY101895A (en) 1992-02-15
HK71295A (en) 1995-05-19
WO1988000587A2 (en) 1988-01-28
DK170213B1 (da) 1995-06-19

Similar Documents

Publication Publication Date Title
ATE71090T1 (de) Heterocyclische verbindungen und deren herstellung und verwendung.
ATE126517T1 (de) Verwendung von bis(3,4- dialkylbenzyliden)sorbitolacetale und diese enthaltende zusammensetzungen.
SE8500307L (sv) Nya, antiviruella medel
DK129189D0 (da) Benzophenonderivater
SE7706392L (sv) N-fosfonometylenmonoaminoalkanmono- och -polyfosfonsyror respektive n-fosfonometylendiaminoalkanpolyfosfonsyror samt sett for deras framstellning
FI881165A0 (fi) 5-hetero- eller aryl-substituerade imidazo /2,1-a/ isokinoliner.
DE69106902D1 (de) Imidazopyridazine, ihre Herstellung und Verwendung.
ATE13430T1 (de) Neue benzodioxolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69411616D1 (de) Triazolopyridazin-Derivate, ihre Herstellung und Verwendung
CO4340691A1 (es) 2-HETEROARIL-5,11-DIHIDRO-6H-DIPIRIDO(3,2-b:2´, 3´ -e) (1, 4)-DIAZEPINAS .
FR2491470B1 (fi)
ATE5144T1 (de) Thiazolderivate, ihre herstellung und ihre therapeutische anwendung.
ATE55123T1 (de) Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.
SE398116B (sv) Analogiforfarande for framstellning av cyklohexenylkarbamider
FI920656A0 (fi) Foerfarande foer framstaellning av disubstituerade urea- och tioureaderivat.
ATE75747T1 (de) Verfahren zur herstellung von antibiotika.
TH3183A (th) อนุพันธุ์ของอัลโลแฟนเนท
TH3183EX (th) อนุพันธุ์ของอัลโลแฟนเนท
EP0396078A3 (de) 1-Hydroxi-azolverbindungen und diese enthaltende Fungizide

Legal Events

Date Code Title Description
FG Patent granted

Owner name: INSTRUMENTARIUM OY

BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed

Owner name: NOVARTIS AG